Related Experiment Video
Updated: Jul 16, 2026

12:34
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
Published on: January 3, 2020
16.8K
ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial:
Karl-Friedrich Kowalewski1, Marie Angela Sidoti Abate2, Manuel Neuberger2
1Department of Urology and Urological Surgery, University Medical Centre Mannheim, Mannheim, Germany karl-friedrich.kowalewski@umm.de.
BMJ Open
|November 4, 2021
Summary
This feasibility trial will assess robotic-assisted partial nephrectomy (RAPN) versus open partial nephrectomy (OPN) for renal neoplasms. Recruitment feasibility is the primary goal, paving the way for future phase III trials.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Limited randomized controlled trials exist comparing robotic-assisted partial nephrectomy (RAPN) and open partial nephrectomy (OPN).
- There is a need to evaluate the feasibility and outcomes of RAPN versus OPN for renal neoplasms.
Purpose of the Study:
- To report the study protocol for a randomized controlled feasibility trial comparing RAPN and OPN.
- To assess the feasibility of recruitment for a trial comparing these two surgical approaches.
- To gather preliminary data on perioperative results, quality of life, and surgical ergonomics.
Main Methods:
- A single-center, randomized, open-label, feasibility trial design.
- Enrollment of 50 patients with renal neoplasms suitable for both RAPN and OPN.
- 1:1 allocation ratio with feasibility of recruitment as the primary endpoint (success if 1/3 eligible patients consent).
Main Results:
- The primary outcome is the feasibility of patient recruitment.
- Secondary endpoints include perioperative outcomes, health-related quality of life, inflammatory response, and surgical ergonomics.
- Results will inform the design of a future phase III trial if recruitment is feasible.
Conclusions:
- This feasibility trial is crucial for establishing the groundwork for a larger, confirmative phase III study.
- Successful recruitment will validate the comparison of RAPN and OPN in a randomized setting.
- The study aims to provide essential data for optimizing surgical management of renal neoplasms.

